Comparative trial of oral clotrimazole and nystatin for oropharyngeal candidiasis prophylaxis in orthotopic liver transplant patients

James D. Ruskin, R. Patrick Wood, Michael R. Bailey, Cherie K. Whitmore, Byers W. Shaw

Research output: Contribution to journalArticle

28 Citations (Scopus)

Abstract

A prospective randomized study was conducted to assess the effectiveness of clotrimazole troches and nystatin suspension to prevent oral candidiasis in immunosuppressed orthotopic liver transplant patients. Thirty-four patients received either clotrimazole troches, 10 mg, five times daily, or nystatin suspension, 500,000 units, four times daily. Prophylaxis was initiated after extubation after transplantation and continued throughout the hospitalization. One of 17 patients in each treatment group developed clinical and microscopic evidence of an oropharyngealCandida infection. This gave an intragroup and an overall infection rate of 5.9%. It appears that either nystatin or clotrimazole may be used for candidiasis prophylaxis in orthotopic liver transplant patients.

Original languageEnglish (US)
Pages (from-to)567-571
Number of pages5
JournalOral Surgery, Oral Medicine, Oral Pathology
Volume74
Issue number5
DOIs
StatePublished - Nov 1992

Fingerprint

Clotrimazole
Nystatin
Candidiasis
Transplants
Liver
Suspensions
Oral Candidiasis
Infection
Hospitalization
Transplantation
Prospective Studies

ASJC Scopus subject areas

  • Pathology and Forensic Medicine
  • Dentistry(all)

Cite this

Comparative trial of oral clotrimazole and nystatin for oropharyngeal candidiasis prophylaxis in orthotopic liver transplant patients. / Ruskin, James D.; Wood, R. Patrick; Bailey, Michael R.; Whitmore, Cherie K.; Shaw, Byers W.

In: Oral Surgery, Oral Medicine, Oral Pathology, Vol. 74, No. 5, 11.1992, p. 567-571.

Research output: Contribution to journalArticle

Ruskin, James D. ; Wood, R. Patrick ; Bailey, Michael R. ; Whitmore, Cherie K. ; Shaw, Byers W. / Comparative trial of oral clotrimazole and nystatin for oropharyngeal candidiasis prophylaxis in orthotopic liver transplant patients. In: Oral Surgery, Oral Medicine, Oral Pathology. 1992 ; Vol. 74, No. 5. pp. 567-571.
@article{b8a622bbf19148eda33f407f14747c85,
title = "Comparative trial of oral clotrimazole and nystatin for oropharyngeal candidiasis prophylaxis in orthotopic liver transplant patients",
abstract = "A prospective randomized study was conducted to assess the effectiveness of clotrimazole troches and nystatin suspension to prevent oral candidiasis in immunosuppressed orthotopic liver transplant patients. Thirty-four patients received either clotrimazole troches, 10 mg, five times daily, or nystatin suspension, 500,000 units, four times daily. Prophylaxis was initiated after extubation after transplantation and continued throughout the hospitalization. One of 17 patients in each treatment group developed clinical and microscopic evidence of an oropharyngealCandida infection. This gave an intragroup and an overall infection rate of 5.9{\%}. It appears that either nystatin or clotrimazole may be used for candidiasis prophylaxis in orthotopic liver transplant patients.",
author = "Ruskin, {James D.} and Wood, {R. Patrick} and Bailey, {Michael R.} and Whitmore, {Cherie K.} and Shaw, {Byers W.}",
year = "1992",
month = "11",
doi = "10.1016/0030-4220(92)90345-Q",
language = "English (US)",
volume = "74",
pages = "567--571",
journal = "Oral Surgery, Oral Medicine, Oral Pathology and Oral Radiology",
issn = "2212-4403",
publisher = "Elsevier USA",
number = "5",

}

TY - JOUR

T1 - Comparative trial of oral clotrimazole and nystatin for oropharyngeal candidiasis prophylaxis in orthotopic liver transplant patients

AU - Ruskin, James D.

AU - Wood, R. Patrick

AU - Bailey, Michael R.

AU - Whitmore, Cherie K.

AU - Shaw, Byers W.

PY - 1992/11

Y1 - 1992/11

N2 - A prospective randomized study was conducted to assess the effectiveness of clotrimazole troches and nystatin suspension to prevent oral candidiasis in immunosuppressed orthotopic liver transplant patients. Thirty-four patients received either clotrimazole troches, 10 mg, five times daily, or nystatin suspension, 500,000 units, four times daily. Prophylaxis was initiated after extubation after transplantation and continued throughout the hospitalization. One of 17 patients in each treatment group developed clinical and microscopic evidence of an oropharyngealCandida infection. This gave an intragroup and an overall infection rate of 5.9%. It appears that either nystatin or clotrimazole may be used for candidiasis prophylaxis in orthotopic liver transplant patients.

AB - A prospective randomized study was conducted to assess the effectiveness of clotrimazole troches and nystatin suspension to prevent oral candidiasis in immunosuppressed orthotopic liver transplant patients. Thirty-four patients received either clotrimazole troches, 10 mg, five times daily, or nystatin suspension, 500,000 units, four times daily. Prophylaxis was initiated after extubation after transplantation and continued throughout the hospitalization. One of 17 patients in each treatment group developed clinical and microscopic evidence of an oropharyngealCandida infection. This gave an intragroup and an overall infection rate of 5.9%. It appears that either nystatin or clotrimazole may be used for candidiasis prophylaxis in orthotopic liver transplant patients.

UR - http://www.scopus.com/inward/record.url?scp=0026496247&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0026496247&partnerID=8YFLogxK

U2 - 10.1016/0030-4220(92)90345-Q

DO - 10.1016/0030-4220(92)90345-Q

M3 - Article

C2 - 1437059

AN - SCOPUS:0026496247

VL - 74

SP - 567

EP - 571

JO - Oral Surgery, Oral Medicine, Oral Pathology and Oral Radiology

JF - Oral Surgery, Oral Medicine, Oral Pathology and Oral Radiology

SN - 2212-4403

IS - 5

ER -